{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T15:13:11Z","timestamp":1785683591569,"version":"3.56.0"},"reference-count":102,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.jaad.2021.11.068","type":"journal-article","created":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T11:05:03Z","timestamp":1661598303000},"page":"965-980","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["An update on viral-induced cutaneous lymphoproliferative disorders. CME Part I"],"prefix":"10.1016","volume":"88","author":[{"given":"Jose A.","family":"Plaza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro A.","family":"Gru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar P.","family":"Sangueza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia V.","family":"Lourenco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco B.","family":"Puccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose A.","family":"Sanches","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Miyashiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Toussaint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin J.","family":"Sangueza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.jaad.2021.11.068_bib1","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1002\/ijc.21731","article-title":"The global health burden of infection-associated cancers in the year 2002","volume":"118","author":"Parkin","year":"2006","journal-title":"Int J Cancer"},{"issue":"6","key":"10.1016\/j.jaad.2021.11.068_bib2","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1111\/bjh.15789","article-title":"Epidemiology, outcome, targeted agents and immunotherapy in adolescent and young adult non-Hodgkin and Hodgkin lymphoma","volume":"185","author":"Metzger","year":"2019","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.jaad.2021.11.068_bib3","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ejca.2006.10.008","article-title":"Time trends in the registration of Hodgkin and non-Hodgkin lymphomas in Europe","volume":"43","author":"Adamson","year":"2007","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.jaad.2021.11.068_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00277-004-0939-7","article-title":"Epidemiology of non-Hodgkin\u2019s lymphoma (NHL): trends, geographic distribution, and etiology","volume":"84","author":"M\u00fcller","year":"2005","journal-title":"Ann Hematol"},{"issue":"4","key":"10.1016\/j.jaad.2021.11.068_bib5","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1158\/1055-9965.EPI-05-0549","article-title":"Changes in cancer registry coding for lymphoma subtypes: reliability over time and relevance for surveillance and study","volume":"15","author":"Clarke","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"10.1016\/j.jaad.2021.11.068_bib6","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"issue":"24","key":"10.1016\/j.jaad.2021.11.068_bib7","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1093\/jnci\/djr483","article-title":"Preventable exposures associated with human cancers","volume":"103","author":"Cogliano","year":"2011","journal-title":"J Natl Cancer Inst"},{"issue":"24","key":"10.1016\/j.jaad.2021.11.068_bib8","doi-asserted-by":"crossref","first-page":"4795","DOI":"10.1182\/blood-2012-07-440073","article-title":"Classification of non-Hodgkin lymphoma in Central and South America: a review of 1028 cases","volume":"120","author":"Laurini","year":"2012","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.jaad.2021.11.068_bib9","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1097\/PAS.0000000000001495","article-title":"Comparison of systemic EBV-positive T-cell and NK-cell lymphoproliferative diseases of childhood based on classification evolution: new classification, old problems","volume":"44","author":"Chen","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"20","key":"10.1016\/j.jaad.2021.11.068_bib10","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jaad.2021.11.068_bib11","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1365-2133.2010.09789.x","article-title":"Epstein-Barr virus involvement in the pathogenesis of hydroa vacciniforme: an assessment of seven adult patients with long-term follow-up","volume":"163","author":"Verneuil","year":"2010","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2021.11.068_bib12","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jaad.2013.01.037","article-title":"Hydroa vacciniforme-like cutaneous T-cell lymphoma: clinicopathologic and immunohistochemical study of 12 cases","volume":"69","author":"Sangueza","year":"2013","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2021.11.068_bib13","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/DAD.0000000000000158","article-title":"Hydroa vacciniforme-like lymphoma with primarily periorbital swelling: 7 cases of an atypical clinical manifestation of this rare cutaneous T-cell lymphoma","volume":"37","author":"Plaza","year":"2015","journal-title":"Am J Dermatopathol"},{"issue":"26","key":"10.1016\/j.jaad.2021.11.068_bib14","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1182\/blood.2018893750","article-title":"Hydroa vacciniforme-like lymphoproliferative disorder: an EBV disease with a low risk\u00a0of systemic illness in whites","volume":"133","author":"Cohen","year":"2019","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jaad.2021.11.068_bib15","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.jaad.2019.01.011","article-title":"Hydroa vacciniforme-like lymphoproliferative disorder: clinicopathologic study of 41 cases","volume":"81","author":"Liu","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"18","key":"10.1016\/j.jaad.2021.11.068_bib16","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1182\/blood-2013-05-502203","article-title":"Hydroa vacciniforme-like lymphoma: a chronic EBV+ lymphoproliferative disorder with risk to develop a systemic lymphoma","volume":"122","author":"Quintanilla-Martinez","year":"2013","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.jaad.2021.11.068_bib17","doi-asserted-by":"crossref","first-page":"9314","DOI":"10.3390\/ijms21239314","article-title":"Hydroa vacciniforme and hydroa vacciniforme-like lymphoproliferative disorder: a spectrum of disease phenotypes associated with ultraviolet irradiation and chronic Epstein-Barr virus infection","volume":"21","author":"Chen","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"12","key":"10.1016\/j.jaad.2021.11.068_bib18","doi-asserted-by":"crossref","first-page":"e452","DOI":"10.1111\/ijd.15141","article-title":"Epstein-Barr virus-associated hydroa vacciniforme-like lymphoproliferative syndrome: excellent response to antiviral therapy","volume":"59","author":"\u0130mren","year":"2020","journal-title":"Int J Dermatol"},{"issue":"13","key":"10.1016\/j.jaad.2021.11.068_bib19","doi-asserted-by":"crossref","DOI":"10.2340\/00015555-3556","article-title":"Hydroa vacciniforme-like lymphoproliferative disorder treated with intravenous immunoglobulin: long-term remission without haematopoietic stem cell transplantation or chemotherapy","volume":"100","author":"Ruan","year":"2020","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"10.1016\/j.jaad.2021.11.068_bib20","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13000-019-0859-4","article-title":"Clinicopathological categorization of hydroa vacciniforme-like lymphoproliferative disorder: an analysis of prognostic implications and treatment based on 19 cases","volume":"14","author":"Guo","year":"2019","journal-title":"Diagn Pathol"},{"issue":"1","key":"10.1016\/j.jaad.2021.11.068_bib21","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2015.52","article-title":"Nasal NK\/T-cell lymphoma. A comparative analysis of a Mexican population with the other populations of Latin-America","volume":"7","author":"Avil\u00e9s","year":"2015","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"4","key":"10.1016\/j.jaad.2021.11.068_bib22","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/s11899-015-0292-z","article-title":"The Epstein-Barr virus (EBV) in T cell and NK cell lymphomas: time for a reassessment","volume":"10","author":"Gru","year":"2015","journal-title":"Curr Hematol Malig Rep"},{"issue":"12","key":"10.1016\/j.jaad.2021.11.068_bib23","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/S0046-8177(87)80410-0","article-title":"Expression of natural killer cell markers in non-Hodgkin\u2019s lymphomas","volume":"18","author":"Ng","year":"1987","journal-title":"Hum Pathol"},{"issue":"1 suppl 1","key":"10.1016\/j.jaad.2021.11.068_bib24","first-page":"S8","article-title":"World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. A progress report","volume":"111","author":"Jaffe","year":"1999","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"10.1016\/j.jaad.2021.11.068_bib25","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/PAS.0b013e31824433d8","article-title":"Extranodal NK\/T-cell lymphoma, nasal type, includes cases of natural killer cell and \u03b1\u03b2, \u03b3\u03b4, and \u03b1\u03b2\/\u03b3\u03b4 T-cell origin: a comprehensive clinicopathologic and phenotypic study","volume":"36","author":"Pongpruttipan","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.jaad.2021.11.068_bib26","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/01.pai.0000205062.27174.56","article-title":"Extranodal NK\/T-cell lymphoma, nasal type: study of clinicopathologic and prognosis factors in a series of 78 cases from Peru","volume":"15","author":"Barrionuevo","year":"2007","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"17","key":"10.1016\/j.jaad.2021.11.068_bib27","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1182\/blood-2008-10-185256","article-title":"Clinical differences between nasal and extranasal natural killer\/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project","volume":"113","author":"Au","year":"2009","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.jaad.2021.11.068_bib28","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.ejca.2005.03.010","article-title":"Extranodal nasal type NK\/T-cell lymphoma: elucidating clinical prognostic factors for risk-based stratification of therapy","volume":"41","author":"Lee","year":"2005","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.jaad.2021.11.068_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/PAS.0000000000000312","article-title":"Primary cutaneous NK\/T-cell lymphoma, nasal type and CD56-positive peripheral T-cell lymphoma: a cellular lineage and clinicopathologic study of 60 patients from Asia","volume":"39","author":"Takata","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.jaad.2021.11.068_bib30","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/PAS.0b013e31826731b5","article-title":"Extranodal NK\/T-cell lymphoma, nasal type: a report of 73 cases at MD Anderson Cancer Center","volume":"37","author":"Li","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jaad.2021.11.068_bib31","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1186\/1471-2407-14-890","article-title":"CD30 expression is a novel prognostic indicator in extranodal natural killer\/T-cell lymphoma, nasal type","volume":"14","author":"Li","year":"2014","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.jaad.2021.11.068_bib32","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1177\/106689690401200410","article-title":"Nasal NK\/T cell lymphoma in Taiwan: a clinicopathologic study of 22 cases, with analysis of histologic subtypes, Epstein-Barr virus LMP-1 gene association, and treatment modalities","volume":"12","author":"Kuo","year":"2004","journal-title":"Int J Surg Pathol"},{"issue":"1","key":"10.1016\/j.jaad.2021.11.068_bib33","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1053\/j.semdp.2019.12.004","article-title":"Epstein-Barr virus positive T and NK-cell lymphoproliferations: morphological features and differential diagnosis","volume":"37","author":"Montes-Mojarro","year":"2020","journal-title":"Semin Diagn Pathol"},{"issue":"5","key":"10.1016\/j.jaad.2021.11.068_bib34","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/s41379-019-0415-5","article-title":"Mutational profile and EBV strains of extranodal NK\/T-cell lymphoma, nasal type in Latin America","volume":"33","author":"Montes-Mojarro","year":"2020","journal-title":"Mod Pathol"},{"issue":"10","key":"10.1016\/j.jaad.2021.11.068_bib35","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/ajh.21256","article-title":"Immunohistochemical expression and clinical significance of P-glycoprotein in previously untreated extranodal NK\/T-cell lymphoma, nasal type","volume":"83","author":"Wang","year":"2008","journal-title":"Am J Hematol"},{"issue":"12","key":"10.1016\/j.jaad.2021.11.068_bib36","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1182\/blood-2015-04-639336","article-title":"Risk-adapted therapy for early-stage extranodal nasal-type NK\/T-cell lymphoma: analysis from a multicenter study","volume":"126","author":"Yang","year":"2015","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jaad.2021.11.068_bib37","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/BF02982090","article-title":"L-asparaginase induced durable remission of relapsed nasal NK\/T-cell lymphoma after autologous peripheral blood stem cell transplantation","volume":"74","author":"Nagafuji","year":"2001","journal-title":"Int J Hematol"},{"issue":"14","key":"10.1016\/j.jaad.2021.11.068_bib38","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1080\/10428194.2020.1811864","article-title":"Modified SMILE (mSMILE) and intensity-modulated radiotherapy (IMRT) for extranodal NK-T lymphoma nasal type in a single-center population","volume":"61","author":"ghione","year":"2020","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"10.1016\/j.jaad.2021.11.068_bib39","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1111\/j.1349-7006.2008.00768.x","article-title":"Phase I study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)\/T-cell lymphoma and leukemia","volume":"99","author":"Yamaguchi","year":"2008","journal-title":"Cancer Sci"},{"issue":"6","key":"10.1016\/j.jaad.2021.11.068_bib40","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s11899-016-0355-9","article-title":"Extranodal NK\/T cell lymphoma, nasal type (ENKTL-NT): an update on epidemiology, clinical presentation, and natural history in North American and European cases","volume":"11","author":"Haverkos","year":"2016","journal-title":"Curr Hematol Malig Rep"},{"issue":"35","key":"10.1016\/j.jaad.2021.11.068_bib41","doi-asserted-by":"crossref","first-page":"6027","DOI":"10.1200\/JCO.2009.23.8592","article-title":"Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK\/T-cell lymphoma: Consortium for Improving Survival of Lymphoma study","volume":"27","author":"Kim","year":"2009","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.jaad.2021.11.068_bib42","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13045-018-0559-7","article-title":"Activity of pembrolizumab in relapsed\/refractory NK\/T-cell lymphoma","volume":"11","author":"Li","year":"2018","journal-title":"J Hematol Oncol"},{"issue":"1","key":"10.1016\/j.jaad.2021.11.068_bib43","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000500974","article-title":"Programmed cell death 1 and programmed cell death ligands in extranodal natural killer\/T cell lymphoma: expression pattern and potential prognostic relevance","volume":"143","author":"Muhamad","year":"2020","journal-title":"Acta Haematol"},{"issue":"61","key":"10.1016\/j.jaad.2021.11.068_bib44","doi-asserted-by":"crossref","first-page":"31832","DOI":"10.18632\/oncotarget.25835","article-title":"LEE011 and Ruxolitinib: a synergistic drug combination for natural killer\/T-cell lymphoma (NKTCL)","volume":"9","author":"Hee","year":"2018","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.jaad.2021.11.068_bib45","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s13045-018-0678-1","article-title":"Advances in multiple omics of natural-killer\/T cell lymphoma","volume":"11","author":"Xiong","year":"2018","journal-title":"J Hematol Oncol"},{"issue":"2","key":"10.1016\/j.jaad.2021.11.068_bib46","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1053\/j.semdp.2019.07.010","article-title":"Cutaneous manifestations of adult T-cell leukemia\/lymphoma","volume":"37","author":"Miyashiro","year":"2020","journal-title":"Semin Diagn Pathol"},{"issue":"3","key":"10.1016\/j.jaad.2021.11.068_bib47","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1128\/CMR.00063-09","article-title":"Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1-associated diseases","volume":"23","author":"Gon\u00e7alves","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jaad.2021.11.068_bib48","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3389\/fmicb.2012.00388","article-title":"Epidemiological aspects and world distribution of HTLV-1 infection","volume":"3","author":"Gessain","year":"2012","journal-title":"Front Microbiol"},{"issue":"3","key":"10.1016\/j.jaad.2021.11.068_bib49","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/cncr.32556","article-title":"Epidemiology and survival trend of adult T-cell leukemia\/lymphoma in the United States","volume":"126","author":"Shah","year":"2020","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.jaad.2021.11.068_bib50","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S1473-3099(07)70081-6","article-title":"Human T-lymphotropic virus 1: recent knowledge about an ancient infection","volume":"7","author":"Verdonck","year":"2007","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"10.1016\/j.jaad.2021.11.068_bib51","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1590\/1806-9282.62.07.691","article-title":"Adult T-cell leukemia\/lymphoma","volume":"62","author":"Oliveira","year":"2016","journal-title":"Rev Assoc Med Bras (1992)"},{"issue":"3","key":"10.1016\/j.jaad.2021.11.068_bib52","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-2141.1991.tb08051.x","article-title":"Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87)","volume":"79","author":"Shimoyama","year":"1991","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.jaad.2021.11.068_bib53","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1080\/02841860802657235","article-title":"Adult T-cell leukemia\/lymphoma (ATL) presenting in the skin: clinical, histological and immunohistochemical features of 52 cases","volume":"48","author":"Bittencourt","year":"2009","journal-title":"Acta Oncol"},{"issue":"8","key":"10.1016\/j.jaad.2021.11.068_bib54","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1200\/JCO.18.00501","article-title":"Revised adult T-cell leukemia-lymphoma international consensus meeting report","volume":"37","author":"Cook","year":"2019","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.jaad.2021.11.068_bib55","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/1346-8138.12328","article-title":"Skin manifestations of adult T-cell leukemia\/lymphoma: clinical, cytological and immunological features","volume":"41","author":"Tokura","year":"2014","journal-title":"J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2021.11.068_bib56","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jaad.2014.10.006","article-title":"Cutaneous manifestations of human T-cell lymphotrophic virus type-1-associated adult T-cell leukemia\/lymphoma: a single-center, retrospective study","volume":"72","author":"Marchetti","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"6-7","key":"10.1016\/j.jaad.2021.11.068_bib57","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.annder.2018.01.049","article-title":"Cutaneous presentation of adult T-cell leukemia\/lymphoma (ATLL). Single-center study on 37 patients in metropolitan France between 1996 and 2016","volume":"145","author":"Hurabielle","year":"2018","journal-title":"Ann Dermatol Venereol"},{"issue":"15","key":"10.1016\/j.jaad.2021.11.068_bib58","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1182\/blood-2010-11-316794","article-title":"Type of skin eruption is an independent prognostic indicator for adult T-cell leukemia\/lymphoma","volume":"117","author":"Sawada","year":"2011","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.jaad.2021.11.068_bib59","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/j.1346-8138.1999.tb02093.x","article-title":"Clinicopathologic analysis of 124 cases of adult T-cell leukemia\/lymphoma with cutaneous manifestations: the smouldering type with skin manifestations has a poorer prognosis than previously thought","volume":"26","author":"Setoyama","year":"1999","journal-title":"J Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2021.11.068_bib60","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/j.1365-4632.2011.04882.x","article-title":"Human T-lymphotropic virus 1 (HTLV-1) infection\u2014dermatological implications","volume":"50","author":"Amano","year":"2011","journal-title":"Int J Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2021.11.068_bib61","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/00000372-199712000-00007","article-title":"Adult T-cell leukemia\/lymphoma associated with noninfectious epithelioid granuloma in the skin: a clinicopathologic study","volume":"19","author":"Setoyama","year":"1997","journal-title":"Am J Dermatopathol"},{"issue":"9","key":"10.1016\/j.jaad.2021.11.068_bib62","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/j.1600-0560.2012.01953.x","article-title":"Adult T-cell leukemia\/lymphoma with follicular mucinosis: an unusual histopathological finding and a commentary","volume":"39","author":"Camp","year":"2012","journal-title":"J Cutan Pathol"},{"issue":"11","key":"10.1016\/j.jaad.2021.11.068_bib63","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/DAD.0000000000000082","article-title":"Adult T-cell leukemia-lymphoma associated with follicular mucinosis","volume":"36","author":"Ballester","year":"2014","journal-title":"Am J Dermatopathol"},{"issue":"12","key":"10.1016\/j.jaad.2021.11.068_bib64","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1346-8138.2009.00722.x","article-title":"Adult T-cell leukemia-lymphoma associated with follicular mucinosis","volume":"36","author":"Wada","year":"2009","journal-title":"J Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2021.11.068_bib65","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1365-2559.1995.tb00272.x","article-title":"CD30 (Ki-1) expression in adult T-cell leukaemia\/lymphoma is associated with distinctive immunohistological and clinical characteristics","volume":"26","author":"Takeshita","year":"1995","journal-title":"Histopathology"},{"issue":"4","key":"10.1016\/j.jaad.2021.11.068_bib66","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1182\/blood.2019004045","article-title":"How I treat adult T-cell leukemia\/lymphoma","volume":"137","author":"Cook","year":"2021","journal-title":"Blood"},{"issue":"27","key":"10.1016\/j.jaad.2021.11.068_bib67","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1200\/JCO.2010.28.0669","article-title":"Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia\/lymphoma showing improved survival in the leukemic subtypes","volume":"28","author":"Bazarbachi","year":"2010","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.jaad.2021.11.068_bib68","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/bjh.13338","article-title":"Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: a randomized phase II study","volume":"169","author":"Ishida","year":"2015","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.jaad.2021.11.068_bib69","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/bjh.15123","article-title":"Follow-up of a randomised phase II study of chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: impact on allogeneic haematopoietic stem cell transplantation","volume":"184","author":"Ishida","year":"2019","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.jaad.2021.11.068_bib70","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.1016\/S2352-3026(15)00284-7","article-title":"Lenalidomide in relapsed adult T-cell leukaemia-lymphoma or peripheral T-cell lymphoma (ATLL-001): a phase 1, multicentre, dose-escalation study","volume":"3","author":"Ogura","year":"2016","journal-title":"Lancet Haematol"},{"issue":"12","key":"10.1016\/j.jaad.2021.11.068_bib71","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1097\/PAS.0b013e3181fd8781","article-title":"Lymphomatoid granulomatosis: insights gained over 4 decades","volume":"34","author":"Katzenstein","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.jaad.2021.11.068_bib72","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0046-8177(72)80005-4","article-title":"Lymphomatoid granulomatosis","volume":"3","author":"Liebow","year":"1972","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1016\/j.jaad.2021.11.068_bib73","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/1097-0142(197901)43:1<360::AID-CNCR2820430151>3.0.CO;2-8","article-title":"Lymphomatoid granulomatosis: a clinicopathologic study of 152 cases","volume":"43","author":"Katzenstein","year":"1979","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.jaad.2021.11.068_bib74","first-page":"435","article-title":"Detection of Epstein-Barr virus genomes in lymphomatoid granulomatosis: analysis of 29 cases by the polymerase chain reaction technique","volume":"3","author":"Katzenstein","year":"1990","journal-title":"Mod Pathol"},{"issue":"8","key":"10.1016\/j.jaad.2021.11.068_bib75","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/00000478-199408000-00001","article-title":"Pulmonary lymphomatoid granulomatosis. Evidence for a proliferation of Epstein-Barr virus infected B-lymphocytes with a prominent T-cell component and vasculitis","volume":"18","author":"Guinee","year":"1994","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"10.1016\/j.jaad.2021.11.068_bib76","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1097\/00000478-199511000-00011","article-title":"Lymphomatoid granulomatosis. Evidence of immunophenotypic diversity and relationship to Epstein-Barr virus infection","volume":"19","author":"Myers","year":"1995","journal-title":"Am J Surg Pathol"},{"issue":"suppl 1","key":"10.1016\/j.jaad.2021.11.068_bib77","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1038\/modpathol.2011.149","article-title":"Current histological diagnosis of lymphomatoid granulomatosis","volume":"25","author":"Colby","year":"2012","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.jaad.2021.11.068_bib78","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1365-2559.1996.tb01415.x","article-title":"Lymphomatoid granulomatosis: evidence that some cases represent Epstein-Barr virus-associated B-cell lymphoma","volume":"29","author":"Nicholson","year":"1996","journal-title":"Histopathology"},{"issue":"7","key":"10.1016\/j.jaad.2021.11.068_bib79","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1136\/jcp.56.7.555","article-title":"Isolated EBV lymphoproliferative disease in a child with Wiskott-Aldrich syndrome manifesting as cutaneous lymphomatoid granulomatosis and responsive to anti-CD20 immunotherapy","volume":"56","author":"Sebire","year":"2003","journal-title":"J Clin Pathol"},{"issue":"1","key":"10.1016\/j.jaad.2021.11.068_bib80","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/sj.bmt.1701513","article-title":"Lymphomatoid granulomatosis following autologous stem cell transplantation","volume":"23","author":"Fassas","year":"1999","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.jaad.2021.11.068_bib81","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1365-2133.2007.08038.x","article-title":"Lymphomatoid granulomatosis complicating other haematological malignancies","volume":"157","author":"Muller","year":"2007","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2021.11.068_bib82","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1001\/archderm.1986.01660150081020","article-title":"Cutaneous lesions of lymphomatoid granulomatosis","volume":"122","author":"Brodell","year":"1986","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2021.11.068_bib83","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/00000372-198100320-00003","article-title":"Cutaneous lesions of lymphomatoid granulomatosis. Comparison with lymphomatoid papulosis","volume":"3","author":"Kessler","year":"1981","journal-title":"Am J Dermatopathol"},{"issue":"4","key":"10.1016\/j.jaad.2021.11.068_bib84","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jdcr.2015.05.008","article-title":"A case of lymphomatoid granulomatosis presenting with cutaneous lesions","volume":"1","author":"Shaigany","year":"2015","journal-title":"JAAD Case Rep"},{"issue":"1","key":"10.1016\/j.jaad.2021.11.068_bib85","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1001\/jamadermatol.2018.2552","article-title":"Necrotic plaque on the distal nose with diffuse crateriform nodules","volume":"155","author":"Pollack","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"9","key":"10.1016\/j.jaad.2021.11.068_bib86","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/00000478-200109000-00001","article-title":"Cutaneous lymphomatoid granulomatosis: correlation of clinical and biologic features","volume":"25","author":"Beaty","year":"2001","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.jaad.2021.11.068_bib87","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-2559.1994.tb01373.x","article-title":"Epstein-Barr virus in cutaneous lymphomatoid granulomatosis","volume":"25","author":"Angel","year":"1994","journal-title":"Histopathology"},{"issue":"6","key":"10.1016\/j.jaad.2021.11.068_bib88","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/DAD.0000000000001301","article-title":"A case of methotrexate-associated lymphoproliferative disorder (lymphomatoid granulomatosis) of the skin","volume":"41","author":"Nishida","year":"2019","journal-title":"Am J Dermatopathol"},{"issue":"20","key":"10.1016\/j.jaad.2021.11.068_bib89","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1056\/NEJM198805193182013","article-title":"Treatment of B-cell lymphoproliferative disorders with interferon alfa and intravenous gamma globulin","volume":"318","author":"Shapiro","year":"1988","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.jaad.2021.11.068_bib90","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.bbmt.2013.07.023","article-title":"Hematopoietic stem cell transplantation in patients with lymphomatoid granulomatosis: a European group for blood and marrow transplantation report","volume":"19","author":"Siegloch","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jaad.2021.11.068_bib91","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/PAS.0b013e3181cf8622","article-title":"EBV positive mucocutaneous ulcer\u2014a study of 26 cases associated with various sources of immunosuppression","volume":"34","author":"Dojcinov","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jaad.2021.11.068_bib92","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40164-016-0042-5","article-title":"Diagnostic and therapeutic challenges of EBV-positive mucocutaneous ulcer: a case report and systematic review of the literature","volume":"5","author":"Roberts","year":"2015","journal-title":"Exp Hematol Oncol"},{"issue":"19","key":"10.1016\/j.jaad.2021.11.068_bib93","doi-asserted-by":"crossref","first-page":"6072","DOI":"10.3748\/wjg.v21.i19.6072","article-title":"Epstein Barr virus-positive mucocutaneous ulcer of the colon associated Hodgkin lymphoma in Crohn\u2019s disease","volume":"21","author":"Moran","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.jaad.2021.11.068_bib94","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/pathogens7010028","article-title":"EBV-positive lymphoproliferations of B- T- and NK-cell derivation in non-immunocompromised hosts","volume":"7","author":"Dojcinov","year":"2018","journal-title":"Pathogens"},{"issue":"5","key":"10.1016\/j.jaad.2021.11.068_bib95","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s12185-011-0943-3","article-title":"Multi-focal EBV-mucocutaneous ulcer heralding late-onset T-cell immunodeficiency in a woman with lupus erythematosus","volume":"94","author":"Au","year":"2011","journal-title":"Int J Hematol"},{"issue":"11","key":"10.1016\/j.jaad.2021.11.068_bib96","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1097\/PAS.0000000000000282","article-title":"EBV-positive mucocutaneous ulcer in organ transplant recipients: a localized indolent posttransplant lymphoproliferative disorder","volume":"38","author":"Hart","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.jaad.2021.11.068_bib97","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/bmt.2015.245","article-title":"Presentation and management of post-allogeneic transplantation EBV-positive mucocutaneous ulcer","volume":"51","author":"Nelson","year":"2016","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1016\/j.jaad.2021.11.068_bib98","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.oooo.2015.06.028","article-title":"EBV-positive mucocutaneous ulcer of the oral cavity associated with HIV\/AIDS","volume":"120","author":"Bunn","year":"2015","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"2","key":"10.1016\/j.jaad.2021.11.068_bib99","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3960\/jslrt.18039","article-title":"A review of EBV-positive mucocutaneous ulcers focusing on clinical and pathological aspects","volume":"59","author":"Ikeda","year":"2019","journal-title":"J Clin Exp Hematop"},{"issue":"2","key":"10.1016\/j.jaad.2021.11.068_bib100","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/ajcp\/aqw214","article-title":"EBV-positive B-cell proliferations of varied malignant potential: 2015 SH\/EAHP workshop report-part 1","volume":"147","author":"Natkunam","year":"2017","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"10.1016\/j.jaad.2021.11.068_bib101","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/PAS.0000000000001186","article-title":"The spectrum of EBV-positive mucocutaneous ulcer: a study of 9 cases","volume":"43","author":"Prieto-Torres","year":"2019","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.jaad.2021.11.068_bib102","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/pin.12745","article-title":"EBV-positive mucocutaneous ulcer arising in rheumatoid arthritis patients treated with methotrexate: single center series of nine cases","volume":"69","author":"Satou","year":"2019","journal-title":"Pathol Int"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096222202610X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096222202610X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T23:25:56Z","timestamp":1759274756000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019096222202610X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":102,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S019096222202610X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2021.11.068","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An update on viral-induced cutaneous lymphoproliferative disorders. CME Part I","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2021.11.068","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2022.07.063","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}